CVR: 39177749
Previous names: Hyamedix IVS
DKK 1,843,335
Gross profit
Net result: DKK -886,857
Ginnerup Capital ApS, Vivida ApS
3 more
CVR · view ownership and management
Director role ended: Todd Andrew Kenworth
CVR · 22/09/2023
View the full event history
Hyamedix ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Hyamedix IVS. The management consists of Michael Foldager Johansen, Birgit Fuhlendorff and Khadija Schwach-Abdellaoui. The company's owners include Ginnerup Capital ApS, Vivida ApS and Ginkgo ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,843,335 and a net result of DKK -886,857 compared with DKK -1,370,702 the year before. Equity in the 2025 report amounted to DKK -10,060,273.
Source: annual report 2025, Danish Business Authority
Hyamedix ApS is currently facing significant financial challenges, as indicated by its declining equity position and consistent losses over the past five years. The company's gross profit has fluctuated, with a notable improvement to 1,843,335 DKK in 2025, but it still reported a loss of 886,857 DKK. Equity has deteriorated from -3,855,410 DKK in 2021 to -10,060,273 DKK in 2025, raising concerns about its long-term viability. Without disclosed revenue figures, the lack of profitability and increasing debt suggest a precarious position within the pharmaceutical raw materials manufacturing industry.
AI-generated summary · Generated 14/08/2026
Selskabets formål er at eje teknologier til udlicensiering eller eje kapitalandele i andre virksomheder samt enhver hermed beslægtet virksomhed og drift.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -887 t. | 1.6 mio. | -10.1 mio. | 2 | |
| 202401/01/2024 – 31/12/2024 | - | -1.4 mio. | 2.3 mio. | -9.2 mio. | 2 | |
| 202301/01/2023 – 31/12/2023 | - | -2.8 mio. | 4.5 mio. | -7.8 mio. | 2 | |
| 202201/01/2022 – 31/12/2022 | - | -5.2 mio. | 1.9 mio. | -5.1 mio. | 3 | |
| 202101/01/2021 – 31/12/2021 | - | -6 mio. | 3.6 mio. | -3.9 mio. | 3 | |
| 202001/01/2020 – 31/12/2020 | - | -486 t. | 2.3 mio. | 1.5 mio. | 3 | |
| 201901/01/2019 – 31/12/2019 | 2.6 mio. | 8 t. | 1.2 mio. | 9 t. | - | |
| 201801/01/2018 – 31/12/2018 | 954 t. | 0 | 1 mio. | 1 t. | - |
Compared to 25 companies in Fremstilling af farmaceutiske råvarer
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningHyamedix ApS was founded on 15 December 2017.
Hyamedix ApS is registered under the industry Fremstilling af farmaceutiske råvarer (industry code 211000).
Hyamedix ApS had 1 employee in 2018 according to the Danish CVR register.
The owners of Hyamedix ApS include Ginnerup Capital ApS, Vivida ApS and Ginkgo ApS.
hyamedix.com belongs to Hyamedix ApS, CVR number 39177749.
In 2025, Hyamedix ApS reported a gross profit of DKK 1,843,335.
Claim this page to add your logo and social links. Free to get started.
Hyamedix ApS has published its annual report for 2025. Gross profit came to DKK 1,843,335, and the net result was DKK -886,857.
Contact info changed: new website: www.hyamedix.com (May 13, 2026).
Contact info changed: new website: www.hyamedix.com (January 13, 2026).
Hyamedix ApS has published its annual report for 2024. Gross profit came to DKK -35,972, and the net result was DKK -1,370,702.
Hyamedix ApS has published its annual report for 2023. Gross profit came to DKK 48,090, and the net result was DKK -2,750,562.
As of September 22, 2023, Khadija Schwach-Abdellaoui has joined the board of directors of Hyamedix ApS.
As of September 22, 2023, Todd Andrew Kenworth has left the board of directors of Hyamedix ApS.
As of September 22, 2023, Birgit Fuhlendorff is registered as director of Hyamedix ApS.
As of September 22, 2023, Khadija Schwach-Abdellaoui is registered as director of Hyamedix ApS.
As of September 22, 2023, Todd Andrew Kenworth has stepped down as adm. dir. of Hyamedix ApS.
As of September 22, 2023, Ginnerup Capital ApS is registered as an owner of Hyamedix ApS with an ownership share of 15%.
As of September 22, 2023, Ginkgo ApS is registered as an owner of Hyamedix ApS with an ownership share of 5%.
As of September 22, 2023, Jafa Holding ApS is registered as an owner of Hyamedix ApS with an ownership share of 5%.
As of September 22, 2023, is registered as an owner of Hyamedix ApS with an ownership share of 5%.
Hyamedix ApS has published its annual report for 2022. Gross profit came to DKK -2,134,119, and the net result was DKK -5,206,549.
Hyamedix ApS has published its annual report for 2021. Gross profit came to DKK -2,704,595, and the net result was DKK -5,973,634.
As of June 10, 2022, Timothy James Eviston has left the board of directors of Hyamedix ApS.
As of September 24, 2021, Timothy James Eviston has joined the board of directors of Hyamedix ApS.
Hyamedix ApS has published its annual report for 2020. Gross profit came to DKK 1,401,990, and the net result was DKK -486,357.
As of December 11, 2020, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Hyamedix ApS.
As of December 11, 2020, Jesper Ahlmann Funding Andersen has joined the board of directors of Hyamedix ApS.
On June 4, 2020, the company changed its name from Hyamedix IVS to Hyamedix ApS.
Hyamedix ApS has published its annual report for 2019. Revenue came to DKK 2,555,519, and the net result was DKK 8,138.
Hyamedix ApS has published its annual report for 2018. Revenue came to DKK 953,788, and the net result was DKK 0.
Hyamedix ApS has published its interim report for the period December 15, 2017 – December 31, 2017.
As of December 15, 2017, Todd Andrew Kenworth has joined the board of directors of Hyamedix ApS.
As of December 15, 2017, Michael Foldager Johansen has joined the board of directors of Hyamedix ApS.
As of December 15, 2017, Todd Andrew Kenworth is registered as adm. dir. of Hyamedix ApS.
As of December 15, 2017, Michael Foldager Johansen is registered as adm. dir. of Hyamedix ApS.
As of December 15, 2017, Vivida ApS is registered as an owner of Hyamedix ApS with an ownership share of 33%.
Hyamedix ApS was founded on December 15, 2017.
Companies in the same industry and area
CVR 12783388
CVR 35442723
CVR 45239128
CVR 39014149
CVR 36718277
